Receptors for factors of the VEGF family;Les recepteurs pour les facteurs de la familie du VEGF

Bulletin du Cancer

Volumn 84, Issue 4, 1997, Pages 397-403

  Fournier, Emmanuel ^a   Birnbaum, Daniel ^a   Borg, Jean Paul ^b  

^a INSERM   (France)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

angiogenesis; growth factors; receptors; tyrosine kinases

Indexed keywords

GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR;

ANGIOGENESIS; CANCER; HUMAN; REVIEW; ADULT; GENE EXPRESSION REGULATION; GENETICS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ADULT; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR;

EID: 0031113277     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987 ; 235 : 442-7.
2. Mustonen T, Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 1995 ; 4 : 895-8.
3. Davis S, Aldrich T, Jones P, Acheson A, Compton D, Jain V, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996 ; 87 : 1161-9.
4. Breier G, Risau W. The role of vascular endothelial growth factor in blood vessel formation. Trends Cell Biol 1996 ; 6 : 454-6.
5. Senger D, Van De Water L, Brown L, Nagy J, Yeo KT, Yeo TK, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993 ; 12 : 303-24.
6. Thomas K. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996 ; 271 : 603-6.
7. Mattei MG, Borg J-P, Rosnet O, Marmé D, Birnbaum D. Chromosomal assignment of vascular endothelial growth factor (VEGF) and placental growth factor (PIGF) to chromosome 6p12-p21 and 14q24-q31 regions, respectively. Genomics 1996 ; 32 : 168-9.
8. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996 ; 380 : 435-9.
9. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996 ; 380 : 439-42.
10. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996 ; 15 : 290-8.
11. Lee J, Gray A, Yuan J, Luoh S-M, Avraham H, Wood WI. Vascular endothelial growth factor-related protein : a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sc USA 1996 ; 93 : 1988-92.
12. Olofsson B, Pajusola K, Kaipainen A, Von Euler G, Joukov V, Saksela O, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996 ; 93 : 2576-81.
13. Paavonen K, Horelli-Kuitunen N, Chilov D, Kukk E, Pennanen S, Kallionemi OP, et al. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation 1996 ; 93 : 1079-82.
14. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991 ; 88 : 9267-71.
15. Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994 ; 269 : 25646-54.
16. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 1996 ; 93 : 11675-80.
17. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 1990 ; 5 : 519-24.
18. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991 ; 6 : 1677-83.
19. Pajusola K, Aprelikova O, Korhonen J, Kaipanen A, Pertovaara L, Alitalo R, Alitalo K. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 1992 ; 52 : 5738-43.
20. Galland F, Karamysheva A, Pèbusque MJ, Borg JP, Rottapel R, Dubreuil P, et al. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 1993 ; 8 : 1233-40.
21. Spritz R, Strunk K, Lee S, Lu Kuo JM, Ward DC, Le Paslier D, et al. A YAC spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12. Genomics 1994 ; 22 : 431-6.
22. 19H, and Rw on chromosome 5. Proc Natl Acad Sci USA 1994 ; 91 : 7237-41.
23. Imbert A, Rosnet O, Marchetto S, Ollendorff V, Birnbaum D. Characterization of a yeast artificial chromosome from human chromosome band 13q12 containing the FLT1 and FLT3 receptor-type tyrosine kinase genes. Cytogenet Cell Genet 1994 ; 67 : 175-7.
24. Armstrong E, Kastury K, Aprelikova O, Bullrich F, Nezelof C, Gogusev J, et al. FLT4 receptor tyrosine kinase gene mapping to chromosome band 5q35 in relation to the t(2;5), t(5;6) and t(3;5) translocations. Genes Chromosom Cancer 1993 ; 7 : 144-51.
25. Pèbusque MJ, Lafage-Pochitaloff M, Galland F, Simonetti J, Armstrong E, Rimokh R, Birnbaum D. Localization of two tyrosine kinase receptor genes with respect to the 5q35 chromosomal breakpoint of Ki-1 lymphoma cell lines. Genes Chromosom Cancer 1993 ; 8 : 119-26.
26. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992 ; 255 : 989-91.
27. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Comm 1992 ; 187 : 1579-86.
28. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPH, Risau W, Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993 ; 72 : 835-46.
29. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 1993 ; 90 : 7533-7.
30. Davis-Smyth T, Chen H, Park J, Presto LG, Ferrara N. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt 1 determines ligand binding and may initiate a signal transduction cascade. EMBO J 1996 ; 15 : 4919-27.
31. Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H, Ferrara N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. J Biol Chem 1996 ; 271 : 5638-46.
32. Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993 ; 90 : 10705-9.
33. Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Comm 1996 ; 226 : 324-8.
34. Pajusola K, Aprelikova O, Armstrong E, Morris S, Alitalo K. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. Oncogene 1993 ; 8 : 2931-7.
35. Borg J-P, de Lapeyrière O, Noguchi T, Rottapel R, Dubreuil P, Birnbaum D. Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase. Oncogene 1995 ; 10 : 973-84.
36. Fournier E, Rosnet O, Marchetto S, Turck CW, Rottapel R, Pelicci PG, et al. Interaction with the phosphoryrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase. J Biol Chem 1996 ; 271 : 12956-63.
37. Morishita K, Johnson DE, Williams LT. A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression. J Biol Chem 1995 ; 270 : 27948-53.
38. Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico MG, Terman BI, Alitalo K. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med 1993 ; 178 : 2077-88.
39. Kaipanen A, Korhonen J, Mustonen T, Van Hinsbergh VWM, Fang GH, Dumont D, et al. Expression of the fms-like tyrosine 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995 ; 92 : 3566-70.
40. Kukk Z, Lymboussaki A, Taira S, Kaipanen A, Jeltsch M, Joukov V, Alitalo K. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 1996 ; 122 : 3829-37.
41. Eichmann A, Marcelle C, Breant C, Le Douarin NM. Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development. Mech Dev 1993 ; 42 : 33-48.
42. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J. Flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 1993 ; 118 : 489-98.
43. Peters K, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993 ; 90 : 8916-9.
44. Shabby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995 ; 376 : 62-6.
45. Fong G-H, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995 ; 376 : 66-70.
46. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994 ; 269 : 26988-95.
47. Pajusola K, Aprelikova O, Pelicci G, Weich H, Claesson-Welsh L, Alitalo K. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 1994 ; 9 : 3545-55.
48. Guo D, Jia Q, Song H-Y, Warren RS, Donner DB. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. J Biol Chem 1995 ; 270 : 6729-33.
49. Cunningham S, Waxham N, Arrate P, Brock T. Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 1995 ; 35 : 20254-7.
50. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 1995 ; 10 : 135-47.
51. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nafure 1992 ; 359 : 843-5.
52. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 1996 ; 97 : 469-76.
53. Plate KH, Breier G, Millauer B, Ullrich A, Risau W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 1993 ; 53 : 5822-7.
54. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Med 1995 ; 1 : 27-31.
55. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Philips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993 ; 362 : 841-4.
56. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994 ; 367 : 576-9.
57. Levitski A, Gazit A. Tyrosine kinase inhibition : an approach to drug development. Science 1995 ; 267 : 1782-8.
58. Ramakrishnan S, Olson TA, Bautch VL, Mohanraj D. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res 1996 ; 56 : 1324-30.
59. Suri C, Jones P, Patan S, Bartunkova S, Maisonpierre P, Davis S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996 ; 87 : 1171-80.
60. Vikkula M, Boon L, Carraway K, Calvert J, Diamonti J, Goumnerov B, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996 ; 87 : 1181-90.
61. Folkman J, D'Amore P. Blood vessel formation : what is its basis ? Cell 1996 ; 87 : 1153-5.